We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00335205
Recruitment Status : Unknown
Verified June 2006 by Sheba Medical Center.
Recruitment status was:  Recruiting
First Posted : June 9, 2006
Last Update Posted : June 9, 2006
Sponsor:
Collaborator:
Jerusalem Mental Health Center
Information provided by:
Sheba Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Study Completion Date : No date given